ATHERSYS, INC / NEW

Profile

Company Names

ATHERSYS, INC / NEW

Addresses

3201 CARNEGIE AVENUE, CLEVELAND, OH 44115-2634

Phone Numbers

(216) 431-9900

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$12,537,602.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-04-18 
$3,537,600.00 
$3,537,600.00 
$0.00 
 
1
2012-03-09 
$9,000,002.00 
$18,000,004.00 
$9,000,002.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEE 
E. 
BABISS 
DIRECTOR
ATHERSYS, INC / NEW
DANIEL 
 
CAMARDO 
EXECUTIVE OFFICER, DIRECTOR
ATHERSYS, INC / NEW
LAURA 
K. 
CAMPBELL 
EXECUTIVE OFFICER
ATHERSYS, INC / NEW
MAIA 
 
HANSEN 
EXECUTIVE OFFICER
ATHERSYS, INC / NEW
JOHN 
J. 
HARRINGTON 
EXECUTIVE OFFICER, DIRECTOR
ATHERSYS, INC / NEW
ISMAIL 
 
KOLA 
DIRECTOR
ATHERSYS, INC / NEW   |  BIOTIE THERAPIES CORP.   |  HEMANEXT INC.
WILLIAM 
 
LEHMANN 
EXECUTIVE OFFICER
ATHERSYS, INC / NEW   |  HAZELCAST, INC.   |  LIGHTBEND, INC.
GEORGE 
M. 
MILNE 
DIRECTOR
ATHERSYS, INC / NEW
JOSEPH 
 
NOLAN 
DIRECTOR
GINJOINT, LLC   |  CORE SPORTS TECHNOLOGY GROUP, LLC   |  MOTUS GLOBAL, INC.   |  GROWTH CAPITAL 2019, L.P.   |  ATHERSYS, INC / NEW   |  AKAVA THERAPEUTICS INC.   |  EIKONOKLASTES THERAPEUTICS, INC.
LORIN 
J. 
RANDALL 
DIRECTOR
ATHERSYS, INC / NEW   |  TENGION INC   |  NANOSPHERE INC
KASEY 
 
ROSADO 
EXECUTIVE OFFICER
ATHERSYS, INC / NEW
GIL 
 
VAN BOKKELEN 
EXECUTIVE OFFICER, DIRECTOR
ATHERSYS, INC / NEW   |  BELL BIOSYSTEMS, INC.   |  FLOW PHARMA, INC.
JANE 
 
WASMAN 
DIRECTOR
SELLAS LIFE SCIENCES GROUP, INC.   |  ATHERSYS, INC / NEW
JACK 
 
WYSZOMIERSKI 
DIRECTOR
UNIGENE LABORATORIES INC   |  ATHERSYS, INC / NEW
JACK 
L. 
WYSZOMLERSKI 
DIRECTOR
ATHERSYS, INC / NEW
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-05-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-04-18 
2012-03-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2012-03-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
A.G.P/ALLIANCE GLOBAL PARTNERS
8361
NONE
NONE
PIPER JAFFRAY + CO.
665
NONE
NONE
WILLIAM BLAIR + COMPANY
1252
NONE
NONE
FIRST ANALYSIS SECURITIES CORPORATION
10446
NONE
NONE
WBB SECURITIES, LLC
118440